ACADL is widely involved in energy and phospholipid metabolism, and its abnormal expression has been detected in various conditions, including cardiovascular disease, central obesity, nonketotic hyperglycemia, and diabetes [14–17]. This evidence concerns the gene ACADL and Abdominal obesity.